CD4 and breast carcinoma: Similarly, Lei et al. 56 reported that MHC-II+ cancer cells induced Treg expansion while reducing CD4+ effector T cells in tumour-draining lymph nodes of patients with breast cancer, thereby facilitating metastasis and immune evasion.